Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation

Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation Научная публикация

Журнал

Journal of Clinical Medicine
ISSN: 20770383

Вых. Данные

Год: 2023, Том: 12, Номер статьи : 7702, Страниц : DOI: 10.3390/jcm12247702

Ключевые слова

gut microbiome; ulcerativ

Авторы

Tikunov A. ¹ , Fedorets V. ¹ , Shrainer E.V. ^1,2 , Morozov V.V. ¹ , Bystrova V.I. ^1,2 , Tikunova N.V. ¹

Организации

1	Federal State Public Scientific Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia
2	Department of Obstetrics and Gynecology, V. Zelman Institute for Medicine and Psychology, Novosibirsk National Research State University, 630090 Novosibirsk, Russia

Информация о финансировании (1)

Российский научный фонд

РНФ № 21-14-00360

Background and Aims: Ulcerative colitis (UC) is a chronic inflammatory disease that affects many people. One of the possible ways to treat UC is fecal microbiota transplantation (FMT). In this study, changes in the intestinal microbiome and clinical outcomes of 20 patients with UC after FMT were estimated. Methods: FMT enemas were administrated ten times, once a day, and fecal microbiota from three donors was used for each enema. The clinical outcomes were assessed after eight weeks and then via a patient survey. The 16S rRNA profiles of the gut microbiota were compared between three samplings: samples from 20 patients with UC before and after FMT and samples from 18 healthy volunteers. Results: Clinical remission was achieved in 19 (95%) patients at week 8. Adverse events occurred in five patients, including one non-responder. A significant increase in average biodiversity was shown in samples after FMT compared to samples before FMT, as well as a decrease in the proportion of some potentially pathogenic bacteria. Conclusion: The efficacy of FMT for UC treatment was confirmed; however, the duration of remission varied substantially, possibly due to different characteristics of the initial microbiota of patients. Targeted analysis of a patient’s microbiome before FMT could increase the treatment efficacy.

Tikunov A. , Fedorets V. , Shrainer E.V. , Morozov V.V. , Bystrova V.I. , Tikunova N.V.
Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation
Journal of Clinical Medicine. 2023. V.12. 7702 . DOI: 10.3390/jcm12247702 WOS Scopus PMID OpenAlex

Опубликована в печати:

15 дек. 2023 г.

Web of science:	WOS:001130698900001
Scopus:	2-s2.0-85180713547
PMID (PubMed):	38137770
OpenAlex:	W4389794566

БД	Цитирований
Web of science	2
OpenAlex	3